Skip to content
Sorafenib-sorafenat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat


Sorafenib” is the Drug / Molecule content in “Sorafenat”. Sorafenib is a small molecular inhibitor of several tyrosine protein kinases. Sorafenib treatment induces catabolic mechanism that involve cell degradation; which may suppress tumor growth.

 


Indication

Sorafenib is used for the treatment of Primary Kidney Cancer (Advanced Renal Cell Carcinoma) and Advanced Primary Liver Cancer.

DOSAGE AND ADMINISTRATION:

Recommended daily dose is 400 mg (2 X 200 mg tablets) taken twice daily without food (at least 1 hour before or 2 hours after a meal).

SCHEDULE H PRESCRIPTION DRUG – CAUTION

To be sold by retail on the prescription of an Oncologist only.

Note

SIDE EFFECT :

  • Most commonly occurring Cardiac Ischemia, infarction, Hemorrhage, Hypertension, Hand-Foot skin reaction and rash, Gastrointestinal perforation, Wound healing complications.

INTERACTIONS :

  • Interaction with Docetaxel & Doxorubicin : Sorafenib can cause increase in plasma concentration of Docetaxel & Doxorubicin

OVERDOSE :

  • There is no specific treatment for Sorafenib overdose. In cases of suspected overdose Sorafenib should be withheld and supportive care instituted.

Precaution

  • Sorafenib is a prescription drug and should be used under proper medical guidance and advice.
  • Caution has to be taken in case of kidney / liver problems, pregnancy and lactation.

 

Updated On Oct 15, 2019 by Admin

Strength

200 mg

Packing

1 X 120 Tablets (Plastic Container)

Storage

Store in a cool place, protected from light.



Related Products


CIPLA LTD. (INDIA)

Soranib

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

NATCO PHARMA LIMITED (INDIA)

Sorafenat


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Quick Query

Direct to your Phone